American drug developer Novavax Inc said on Tuesday it was doubling its potential Covid-19 vaccine manufacturing capacity to two billion doses annually under a deal with the Serum Institute of India, increasing its shares by around one. 7%. In August, Novavax signed an agreement with the Serum Institute, the world’s …
Read More »Novavax Targets 2 Billion Covid-19 Vaccine Doses With Expanded Agreement With India India News
